Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Faraday Pharmaceuticals, Inc. See All Filings	D	2022-11-07 09:47:03 UTC
Amount To Be Raised $102,826,124 Associated Brokers / Dealers N/A CIK Number 0001614107 Filed Document 0001614107-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-11-07 09:47:03 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Faraday Pharmaceuticals, Inc. See All Filings	D	2019-09-12 13:21:04 UTC
Amount To Be Raised $30,065,949 Associated Brokers / Dealers N/A CIK Number 0001614107 Filed Document 0001614107-19-000002 Exclusions or Exemptions 506b Accepted Date 2019-09-12 13:21:04 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Faraday Pharmaceuticals, Inc. See All Filings	D	2019-03-19 11:30:17 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0001614107 Filed Document 0001614107-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-03-19 11:30:17 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Debt
Faraday Pharmaceuticals, Inc. See All Filings	D/A	2017-02-21 15:47:28 UTC
Amount To Be Raised $32,780,000 Associated Brokers / Dealers N/A CIK Number 0001614107 Filed Document 0001614107-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-02-21 15:47:28 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Faraday Pharmaceuticals, Inc. See All Filings	D	2014-07-23 00:00:00 UTC
Amount To Be Raised $6,507,274 Associated Brokers / Dealers N/A CIK Number 0001614107 Filed Document 0001614107-14-000001 Exclusions or Exemptions 506b Accepted Date 2014-07-23 00:00:00 UTC Type of Offering D Industry Other Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity